8 participants
A Phase I Study of WT1 Peptides to Induce Anti-Leukemia Immune Responses Following Transplantation
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2013-12-10
- Start Date:
- 2007-06-30
- Completion:
- 2013-04-30
Conditions
- Acute Myelogenous Leukemia (AML)
- Chronic Myelogenous Leukemia (CML)
- Acute Lymphoblastic Leukemia (ALL)
- Myelodysplastic Syndrome (MDS)
- B Cell Malignancies
Interventions
- BIOLOGICAL
No Results Yet